Therapeutic Strategies for Duchenne and Becker Dystrophies
- 1 January 2004
- book chapter
- Published by Elsevier in International Review of Cytology
- Vol. 240, 1-30
- https://doi.org/10.1016/s0074-7696(04)40001-1
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophyThe Journal of Gene Medicine, 2002
- Dystrophin expression in the mdx mouse restored by stem cell transplantationNature, 1999
- Progress Toward Gene Therapy of Duchenne Muscular DystrophySeminars in Neurology, 1999
- Myoblast transfer in duchenne muscular dystrophyAnnals of Neurology, 1993
- Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrixNature, 1992
- Retroviral‐mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitroFEBS Letters, 1992
- Human dystrophin expression in mdx mice after intramuscular injection of DNA constructsNature, 1991
- Dystrophin is localized to the plasma membrane of human skeletal muscle fibers by electron‐microscopic cytochemical studyMuscle & Nerve, 1990
- Characterization of Dystrophin in Muscle-Biopsy Specimens from Patients with Duchenne's or Becker's Muscular DystrophyNew England Journal of Medicine, 1988
- Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individualsCell, 1987